Near fatal asthma, challenges of management with coexisting pneumothorax.
- 1Department of Critical Care, College of Medicine, King Saud University, Riyadh, Saudi Arabia.
Abstract
Near-fatal asthma (NFA) is a life-threatening condition often requiring ventilatory support. The coexistence of pneumonia as a precipitating element for NFA with pneumothorax and pneumomediastinum presents significant diagnostic and therapeutic challenges. We report a 28-year-old woman with known bronchial asthma who presented with severe respiratory distress following upper respiratory tract infection symptoms. She was hypoxemic with clinical evidence of severe asthma exacerbation and subcutaneous emphysema. Imaging demonstrated left upper lobe pneumonia and pneumomediastinum, with subsequent development of a large left-sided pneumothorax. Despite aggressive medical therapy, she required tracheal intubation and chest tube insertion. Management included lung-protective ventilation, meticulous management of ventilator settings, measures to reduce airway resistance and inflammation along with broad-spectrum antibiotics and systemic corticosteroids. The patient improved clinically and radiologically, was successfully extubated, and discharged in stable condition. This case highlights the complex interplay between infection, airway inflammation, and spontaneous barotrauma, emphasizing the importance of early recognition and individualized ventilatory strategies to optimize the outcome.
Related
- Challenges in the diagnosis and management of coexisting drop-head syndrome and dysphagia: a case report and review of the literature.
- Comorbidity Burden and Clinical Management Challenges in Severe Asthma: Insights from a Pan-European SHARP Study
- Case Report: Catamenial pneumothorax: clinical characteristics, diagnosis, and management — a report of two cases with a review of the literature
- Primary bronchial fibrous histiocytoma mimicking refractory asthma in a child: A fatal case of misdiagnosis and airway obstruction.
- Perioperative Management of Coexisting Mast Cell Activation Syndrome and Malignant Hyperthermia Susceptibility: A Case Report and Novel Approach to Local Analgesia.
BibTeX
@article{aljamaan2026near,
title = {{Near fatal asthma, challenges of management with coexisting pneumothorax.}},
author = {Fadi Aljamaan},
journal = {Saudi journal of anaesthesia},
year = {2026},
month = oct,
doi = {10.4103/sja.sja_408_26},
url = {https://europepmc.org/article/MED/42960032},
note = {CC BY-NC-SA},
}
RIS
TY - JOUR
TI - Near fatal asthma, challenges of management with coexisting pneumothorax.
AU - Fadi Aljamaan
PY - 2026
DA - 2026/10/01
JO - Saudi journal of anaesthesia
DO - 10.4103/sja.sja_408_26
UR - https://europepmc.org/article/MED/42960032
AB - Near-fatal asthma (NFA) is a life-threatening condition often requiring ventilatory support. The coexistence of pneumonia as a precipitating element for NFA with pneumothorax and pneumomediastinum presents significant diagnostic and therapeutic challenges. We report a 28-year-old woman with known bronchial asthma who presented with severe respiratory distress following upper respiratory tract infection symptoms. She was hypoxemic with clinical evidence of severe asthma exacerbation and subcutaneous emphysema. Imaging demonstrated left upper lobe pneumonia and pneumomediastinum, with subsequent development of a large left-sided pneumothorax. Despite aggressive medical therapy, she required tracheal intubation and chest tube insertion. Management included lung-protective ventilation, meticulous management of ventilator settings, measures to reduce airway resistance and inflammation along with broad-spectrum antibiotics and systemic corticosteroids. The patient improved clinically and radiologically, was successfully extubated, and discharged in stable condition. This case highlights the complex interplay between infection, airway inflammation, and spontaneous barotrauma, emphasizing the importance of early recognition and individualized ventilatory strategies to optimize the outcome.
SN - 1658-354X
SN - 0975-3125
ER -